Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nanosphere refers to two distinct entities. Nanosphere, Inc. developed the Verigene System—a rapid molecular diagnostics platform for infectious diseases and pharmacogenetics. It was acquired by Luminex in mid-2016 and is no longer an independent company. NanoSphere Health Sciences develops nanoparticle-based delivery systems that enhance bioavailability of cannabinoids and other drugs/nutrients via transdermal or mucosal routes. They are commercial with cannabis products in North America and have ongoing expansion into pharmaceuticals like NSAIDs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nanosphere.